Basic Information
| LncRNA/CircRNA Name | PAPAS |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | HCC tissue |
| Expression Pattern | up-regulated |
| Function Description | we found that PAPAS was upregulated both in plasma from patients with HCC and tumors compared with plasma from healthy people and tumor-adjacent healthy tissues. |
| Pubmed ID | 30920025 |
| Year | 2019 |
| Title | LncRNA PAPAS promotes hepatocellular carcinoma by interacting with miR-188-5p. |
External Links
| Links for PAPAS | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |